buckaroo bonzai
Well-Known Member
http://www.bing.com/news/search?q=latest+medbox+news&qpvt=latest+medbox+news&FORM=EPRE
http://www.kioskmarketplace.com/article/219049/Latest-DOJ-marijuana-guidelines-pave-way-for-Medbox-kiosk
Latest DOJ marijuana guidelines pave way for Medbox kiosk
Medbox has announced that its vending machine-like software and hardware system meets the requirements spelled out in an Aug. 29 memo by the U.S. Department of Justice, which issued new guidelines for the legal sale and dispensing of medical marijuana.
Under the new guidelines, the Justice Department will not challenge state laws and prosecutors may not bring cases against individual users unless they violate a list of eight new federal enforcement priorities.
Those guidelines align with the Medbox system's strengths and capabilities, Dr. Bruce Bedrick, CEO of Medbox, said in the announcement.
"We understood early on that the key to our company's success was in developing and building a system that would demonstrate that legal marijuana could be dispensed in a responsible, transparent, and fully compliant manner," Bedrick said. "Moreover, our entire business model was built upon providing the industry with systems and tools that would help uphold laws, aid regulators, and promote compliance."
latest mmj business news--
http://www.bing.com/news/search?q=latest+medical+marijuana+business+news&qpvt=latest+medical+marijuana+business+news&FORM=EPRE
STEAKHOLDERS>>>>
Companies With a Stake in the Marijuana Debate Receive More Good News as Feds Stand Down
NEW YORK, NY--(Marketwired - Sep 5, 2013) - The debate to legalize marijuana in this country cleared another hurdle late last week when U.S. Attorney General Eric Holder reached out to the governors of both Washington and Colorado. Holder told both that the Justice Department would not, for now, stand in the way of those states' laws, which followed voters' approval of ballot measures that legalized recreational marijuana use.
Although the drug will remain illegal and considered a federal crime under the Controlled Substances Act, Holder has instructed his department to stand down. In the call to both governors, Holder did make it clear that he would focus federal enforcement on serious trafficking cases and keeping the drug away from children.
This is good news to those closely watching the debate like publicly traded companies with shareholders excited about each new development that drives the industry closer to generating revenues in legally accepted practices.
Public companies involved in research like biotech and pharmaceutical firms>>,Nuvilex Inc. (OTCQB: NVLX) and >>Cannabis Science, Inc. to companies with dispensaries like >>Medical Marijuana, Inc. to those companies making products including nutraceuticals like >>Hemp, Inc. all benefit from each hurdle cleared in this marijuana debate.
Nineteen states and Washington, DC allow some legal use of marijuana, primarily for medicinal purposes, but both Washington and Colorado have taken that legalization a step further after voters approved a measure allowing for the drug's recreational use.
Washington's Governor, Jay Inslee, said after the call, "We received good news this morning when Attorney General Eric Holder told the governor the federal government would not pre-empt Washington and Colorado as the states implement a highly regulated legalized market for marijuana."
The debate is shifting, and maybe dramatically so, in favor of more acceptance at every level. For those companies that represent the medical marijuana side of the debate, patients will be the winner as there is no such thing as too much research or too many remedies for pain relief.
http://finance.yahoo.com/news/companies-stake-marijuana-debate-receive-123000959.html
Ten Cannabis Industry Rules in Washington State
The Washington State Liquor Control Board issued final rules for the states newborn legal cannabis industry. Here are ten limits in the rules:
Limit on total pot stores. The maximum number of cannabis stores is 334 across the state. Seattle, which currently supports around 100 medical cannabis shops, is slated to get 21 stores.
Limit on total pot production. The cannabis industry in Washington will produce a maximum 40 metric tons of pot per year under the rules. That is equal to 1.4 million ounces per yearan eighth of an ounce for every adult resident in the state. Expect nearly half of that 40 tons to go toward concentrates production, leaving the state with a possible cannabis drought. The liquor board will monitor inventory numbers from both retailers and producers, so they can adjust this if the numbers demand it, but with 4-6 months to get pot to market, Washington State could experience a dope-dry summer next year. Thankfully, if overt government market manipulation causes a communist-bread-style cannabis shortage, well still have a black market which respects the laws of supply and demand.
Limit on pot grow sizes. Production facilities are limited to 30,000 square feet. The state will have three license tiers for producer sizes: up to 2,000 feet, up to 10,000 feet, and up to 30,000 feet.
Limit on per-person licenses. One person may own up to three retail licenses, or may own up to three producer/processor licenses. Retail license holders can not be licensed to produce cannabis. If a person holds multiple licenses, they may not hold more than 33% of the licenses in a county.
Limit on the amount of pot on site. Indoor growers may keep no more than six-months harvest on site. Outdoor growers may have up 1.25 times their annual harvest on site. Retailers may keep no more than four months average inventory on site.
Limit on business location geography. Pot businesses are not permitted within 1,000 feet of schools, parks, libraries, transit centers, recreation centers, licensed child care, and video arcades. Thats an awful lot of buffers. But the new rules measure that 1,000 feet along the path of common travel over public sidewalks and roads, rather than as the crow flies. This is perhaps the most significant change in the rules, and amazing news for potential pot licensees.
Limit on THC in edibles. Pot food stuff may contain no more than 100mg THC. The official cannabis serving size in Washington State is 10mg THC.
Limit on hash oil serving sizes. Hash and hash oil will be sold in individual units of one gram or less.
Limit on retail purchases. Shoppers are limited to buying one ounce of cannabis flowers, 7 grams of hash and hash oil, 16 ounces of pot food, and 72 fluid ounces of weed drinks.
Limit on advertising. Pot shops can have one sign up to 1,600 square inches. Advertising on products may not be false or misleading, promote over-consumption, speak to the therapeutic benefits of cannabis, or depict children, toys, or child-like cartoons. Businesses may not advertise within 1,000 feet of schools, on buses, or on public property, and all advertising must contain health and safety warnings.
The liquor board has a good summary of the rules and much more info on their I-502 Implementation site.
http://blog.sfgate.com/smellthetruth/2013/09/05/ten-cannabis-industry-rules-in-washington-state/
.......cannabis in its natural form is "one of the safest therapeutically active substances known to man. (T)he provisions of the (Controlled Substances) Act permit and require the transfer of marijuana from Schedule I to Schedule II".
25 years following Judge Young's ruling - marijuana IS medicine
http://www.examiner.com/article/25-years-following-judge-young-s-ruling-marijuana-is-medicine
Endexx Corporation and CEN Biotech, Inc. Enter Into Business Contract
http://finance.yahoo.com/news/endexx-corporation-cen-biotech-inc-123000372.html
CAVE CREEK, AZ--(Marketwired - Sep 6, 2013) - Endexx Corporation (OTC Pink: EDXC) provider of M3Hub technology and the Autospense dispense platform, is pleased to announce our new Collaboration Partner, Creative Edge Nutrition(OTC Pink: FITX). The contract is between Endexx and CEN Biotech, Inc., a subsidiary of Creative Edge Nutrition. Endexx has been contracted to provide its proprietary "Seed to Sale" total inventory management, traceability, and compliance platform for a complex and dynamic new business of CEN Biotech, Inc.
Todd Davis, CEO of Endexx stated, "Endexx's mission is to continually form collaboration alliances and partnerships that foster a sustainable industry platform in the Cannabis related markets. Key partners like Creative Edge, provide opportunities to innovate and improve processes and technologies necessary to support each company's business models. This is a high impact alliance that will support significant growth for both companies."
About Endexx:
Endexx Corporation is a micro-cap publicly traded company, representing the interest of its shareholders and collaborating with independent software developers, scientists, engineers, and other companies to build businesses that can thrive collectively in the equity markets. Endexx's team recognizes that individually small companies with new technologies have an extremely difficult time sustaining themselves as stand-alone companies. Through our collaborative practices, individual and group skill sets are better utilized to develop technology and grow the business, while centralizing costs and eliminating redundancies.
The Endexx management team and its advisory group each have at minimum 10-50 years of experience in their respective fields. The business professionals associated with the direction of the company all have experience growing businesses, developing and implementing new technologies and running publicly traded corporations.
Endexx Corporation is ultimately structured to provide a platform for entrepreneurs to thrive, offering maximum return on investment through equity ownership in the parent corporation. Each individual is a shareholder and is encouraged and self-driven to be successful and contribute to the overall objective of increasing shareholder value.
About Dispense Labs
Dispense Labs LLC., has spent several years investing in the research, design and development, and beta testing of Autospense, a one-of-a-kind technologically driven smart system that allows for the automated dispensing of medical marijuana along with precise inventory control, utilizing predictive analytic algorithm and tracking software.
Autospense is a uniquely designed, high-tech automated dispensing system that exceeds industry standards. The software used is specifically designed to properly control transactions and manage inventory. This will significantly improve profitability, accountability, security tracking and customer satisfaction. The Autospense solution can easily be integrated with external software and service solutions as well, allowing for other market alliances and business partners to utilize this core technology to support other industry related ancillary services. The Autospense system is the only total technology solution in the medical marijuana industry today.
Contact: Todd Davis at [email protected]
Contact Endexx via email to receive corporate news and updates at [email protected]
http://www.otcmarkets.com/stock/EDXC/quote, www.endexx.com,www.autospense.com
Safe Harbor Statement
This press release contains forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements regarding potential sales, the success of the company's business, as well as statements that include the word "believe" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Endexx to differ materially from those implied or expressed by such forward-looking statements. This press release speaks as of the date first set forth above, and Endexx assumes no responsibility to update the information included herein for events occurring after the date hereof. Actual results could differ materially from those anticipated due to factors such as the lack of capital, timely development of products, inability to deliver products when ordered, inability of potential customer to pay for ordered products, and political and economic risks inherent in international trade.
About Creative Edge Nutrition, Inc.
Creative Edge Nutrition is a holding company and a Nutritional Supplement Company focused on developing innovative, high quality supplements. The company offers a broad spectrum of capsules, tablets, and powders, as well as science based products in the principal categories of weight management, nutrition challenges, energy and fitness. The Company manufactures under strict GMP guidelines at GMP Certified and/or FDA registered facilities. www.CenergyNutrition.com and https://www.facebook.com/CenergyNutrition
About www.supplementstogo.com
Supplementstogo.com is one of the leading online retailers in the market today for discount supplements! Always focusing on the hottest products and what provides the best results for their customers, Supplements To Go has made a great name for themselves in the world of nutrition. To find out more about SupplementsToGo.com, please view the site www.supplementstogo.com.
About www.a-z-nutrition.com
A-Z-Nutrition.com is one of the best known e-tailers of discount nutritional supplements. Providing its customers over a decade of quality products at the best prices around, A-Z-Nutrition supports its customers with a portal that is easy to use and to the point. To find out more about them, please view their site www.a-z-nutrition.com.
About www.worldclassnutrition.com
World Class Nutrition - Founded in 1999, early in the internet age of web based super stores, World Class Nutrition is a successful nutritional supplement/fitness equipment retailer due to providing their loyal customers top level support and great prices on their favorite supplement brands.
About www.HempNorthAmerica.com
Hemp North America.com will provide premium grade Hemp Protein supplements to those looking for a natural and lactose free product. Consumers can count on us for bringing the latest scientific findings in the supplement world to market. Also all our products can be found for sale and purchase on all the sites we own www.HempNorthAmerica.com www.supplementstogo.com, www.worldclassnutrition.com, www.a-z-nutrition.com
About www.ChianorthAmerica.com
We will have the best value at the best price; The products which will be manufactured in state-of-the-art facilities GMP Certified and FDA Compliant, and packaged and stored in conditions of the highest standard. A few of our goals are to educate the public with current, science-based information, and provide the highest quality natural products. www.ChiaNorthAmerica.com will strive to become the site and brand of choice for health-conscious consumers. Also all our products will be able to be found for sale and purchase on all the sites we own www.ChiaNorthAmerica.com www.supplementstogo.com, www.worldclassnutrition.com, www.a-z-nutrition.com
[h=1]Endexx Secures >Exclusive World Wide Rights< for Medical Marijuana Dispensing Technology[/h]CAVE CREEK, Ariz., Aug. 12, 2013 /PRNewswire/ -- Endexx Corporation OTC: EDXC. Endexx, through its wholly owned subsidiary, Dispense Labs LLC., has secured its "Supply Agreement" and its Intellectual Property "Licensing Agreement" with AutoCrib Inc. This agreement ensures International Exclusive rights for the Autospense tracking, inventory control, dispensing technology platform for the Marijuana and Cannabis industries. The AutoCrib 1000, in Joint Collaboration between AutoCrib Inc. and Dispense Labs LLC. was specifically adapted and designed as a pharmaceutical grade dispense system for both the medical marijuana and recreational markets, as well as, edibles, concentrates, delivery systems, tobacco products, vaporizers, electronic cigarettes and other related products. These agreements solidify a long term and secure business partnership between Endexx Corporation's, Dispense Labs LLC., and AutoCrib Inc.
The Autospense system provides the capability to dispense a wide variety of objects or packages. Depending on their size, Autospense can manage approximately 800- 1000 individual packaged items for dispensing. The system also accepts US currency, credit and debit cards, and stored value devices. Autospense provides a complete user interface platform allowing patients/customers to visually select their chosen items, by price, brand, use and quantity. A full photo library and descriptions of each item assists a patient/customer in purchasing exactly what they need or prefer through an interactive touch screen. The system also provides patient/member verification tools, i.e., biometric fingerprinting, providing protection for the dispensary, retail outlet or health clinic dispensing cannabis related products. Endexx, through Dispense Labs LLC., is now planning, designing and securing access to external technologies and services for a complete enterprise suite platform that enhances the seed to sale tracking, transaction, accountability and compliance solutions for the rapidly growing marijuana industry.
The Autospense solution can be implemented at every point in the supply chain of the marijuana plant: seed, grower, harvest, processing, testing, transportation, pain clinic, alternative medicine facilities, dispensing, inventory control, law enforcement, compliance, Doctors, caregivers, patient possession and the sale. This total solution technology protects the patient/customer and ensures a safe and compliant product. The technology provides a full compliance package for all handlers of the product from seed to sale. Through standardization, Endexx, Dispense Labs, and the M3Hub will foster and nurture a sustainable growth industry.
About Endexx:
Endexx Corporation is a micro-cap publicly traded company, representing the interest of its shareholders and collaborating with independent software developers, scientists, engineers, and other companies to build businesses that can thrive collectively in the equity markets. Endexx's team recognizes that individually small companies with new technologies have an extremely difficult time sustaining themselves as stand-alone companies. Through our collaborative practices, individual and group skill sets are better utilized to develop technology and grow the business, while centralizing costs and eliminating redundancies.
The Endexx management team and its advisory group each have at minimum 10-50 years of experience in their respective fields. The business professionals associated with the direction of the company all have experience growing businesses, developing and implementing new technologies and running publicly traded corporations.
Endexx Corporation is ultimately structured to provide a platform for entrepreneurs to thrive, offering maximum return on investment through equity ownership in the parent corporation. Each individual is a shareholder and is encouraged and self-driven to be successful and contribute to the overall objective of increasing shareholder value.
About Dispense Labs
Dispense Labs LLC., has spent several years investing in the research, design and development, and beta testing of Autospense, a one-of-a-kind technologically driven smart system that allows for the automated dispensing of medical marijuana along with precise inventory control, utilizing predictive analytic algorithm and tracking software.
Autospense is a uniquely designed, high-tech automated dispensing system that exceeds industry standards. The software used is specifically designed to properly control transactions and manage inventory. This will significantly improve profitability, accountability, security tracking and customer satisfaction. The Autospense solution can easily be integrated with external software and service solutions as well, allowing for other market alliances and business partners to utilize this core technology to support other industry related ancillary services. The Autospense system is the only total technology solution in the medical marijuana industry today.
Contact: Todd Davis at [email protected]
Contact Endexx via email to receive corporate news and updates at[email protected]
http://www.otcmarkets.com/stock/EDXC/quote, www.endexx.com,www.autospense.com
Safe Harbor Statement
This press release contains forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements regarding potential sales, the success of the company's business, as well as statements that include the word "believe" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Endexx to differ materially from those implied or expressed by such forward-looking statements. This press release speaks as of the date first set forth above, and Endexx assumes no responsibility to update the information included herein for events occurring after the date hereof. Actual results could differ materially from those anticipated due to factors such as the lack of capital, timely development of products, inability to deliver products when ordered, inability of potential customer to pay for ordered products, and political and economic risks inherent in international trade.
older article but pertinent to the times--
Even if you get compassionate medical cannabis laws passed, the governments and corporations collude to make it impossible to grow your own or operate small growing operations that serve local dispensaries.
http://www.tokeofthetown.com/2012/02/corporation_aims_to_co-opt_medical_marijuana_make.php
more recent news
NTRR: New Horticultural System to Produce Bigger, Better Plants
http://www.fool.com/investing/businesswire/2013/09/05/ntrr-new-horticultural-system-to-produce-bigger-be.aspx
By Business Wire |
September 5, 2013 | Comments (0)
NTRR: New Horticultural System to Produce Bigger, Better Plants
SARASOTA, Fla.--(BUSINESS WIRE)-- As part of its new joint venture with horticultural innovators Surface to Air Solutions, LLC (S2O2), Neutra Corp. (OTCBB: NTRR) is working to help market and develop a sophisticated suite of products calibrated to produce bigger and more resistant plants for use in nutraceutical applications.
S2O2 has delivered advanced, scientific systems that produce a cleaner, healthier growing environment for plants, accelerating photosynthesis, increasing sugar production and boosting resistance to insects, fungus and bacteria.
The results are dramatically improved crop yields as well as improved shelf lifeenormously important in the cultivation of nutraceutical ingredients such as medical marijuana (MMJ). Under the terms of the joint venture agreement signed last week, NTRR will partner with STA to develop and market innovations designed to make indoor and outdoor growing operations easier and more efficient to build and maintain.
NTRR is already working with Vertigo Technologies, LLC, to advance the development and marketing of innovative horticultural production systems. The company is dedicated to developing the advanced technology necessary to more efficiently deliver potent, all-natural options to chronic pain sufferers and others desperately in need of effective treatment.
By providing innovative nutraceutical products and services such as new MMJ breakthroughs, Neutra Corp. plans to follow in the footsteps of other successful public companies including Cannabis Science, Inc. (OTCBB: CBIS), Medical Marijuana Inc. (OTCBB: MJNA) and Terra Tech Corp. (OTCBB: TRTC), delivering technological advancements in the cultivation and processing of cannabis in approved markets.
For more information on NTRRs initiatives, please visit www.neutracorp.com.
NTRR Begins Development of Contaminants Test for Nutraceuticals
SARASOTA, Fla.--(BUSINESS WIRE)--
Neutra Corp. (NTRR), a provider of all-natural wellness solutions, announced today that it began development on a simple, affordable new system for testing nutraceutical concentrates for harmful contaminants.
The project is being led by Dr. Richard C. Kaufman, the companys new head of research and development in the in the $42 billion nutraceuticals industry. The system will be especially useful for testing oils, butters, tinctures, resins and other concentrates derived from medical marijuana (MMJ), says NTRR CEO Sydney Jim.
There are a number of nutraceutical concentrates, especially those related to medicinal cannabis, that can pose significant health risks if contaminated, Mr. Jim said. Many cannabis oils, for example, are extracted using potentially harmful substances such as butane. Weve got plans for an easy, disposable test that will help nutraceutical users determine if their customized remedies are pure and free of contaminants.
Such an innovation could prove to be extremely lucrative for NTRR as interest in marijuana extracts grows by the day. The booming U.S. MMJ sector is forecast to climb to $6 billion in coming years by MMJ Business Dailys Marijuana Business Factbook.
Through its subsidiary, Cannabis Technologies, NTRR is working to help introduce the next wave of healthier, more efficient delivery systems to the ever-growing MMJ market. By providing innovative nutraceutical products and services such as new MMJ breakthroughs, Neutra Corp. plans to follow in the footsteps of other successful public companies including Cannabis Science, Inc. (CBIS), Medical Marijuana Inc. (MJNA) and Terra Tech Corp. (TRTC), delivering technological advancements in the cultivation and processing of cannabis in approved markets.
For more information on NTRRs initiatives, please visit www.neutracorp.com.
http://finance.yahoo.com/news/ntrr-begins-development-contaminants-test-090000085.html
[August 31, 2013] |
digg
(Professional Services Close - Up Via Acquire Media NewsEdge) Neutra Corp., a provider of all-natural wellness solutions, said that the company has begun research and development activities on a new oral delivery system for nutraceuticals including medical marijuana (MMJ)
In a release, the Company said that earlier this month, it hired Dr. Richard C. Kaufman to spearhead this new research and development project as well as others in the $42 billion nutraceuticals industry. The company is close to finalizing a joint venture agreement with Second Wave Ventures, a developer of cannabinoid products infused with healthy nutrients, in order to forge new methods of smokeless THC and CBD delivery.
NTRR said that Cannabinoids found in medical marijuana, such as the substances THC and CBD, have demonstrated several therapeutic benefits in a number of case studies. Recent pre-clinical trials conducted by the FDA suggest that THC-rich cannabis can significantly reduce the onset of neuropathy, and CBD has been found to provide relief from chronic pain due to muscle spasticity, muscle convulsions and inflammation--a type of pain often experienced by patients who suffer from Multiple Sclerosis, Fibromyalgia and Epilepsy.
Through Cannabis Technologies, Inc., NTRR is working to help introduce the next wave of healthier, more efficient systems to the ever-growing $1.7 billion MMJ market. By providing nutraceutical products and services such as new MMJ advancements, Neutra Corp. plans to follow in the footsteps of other successful public companies including Medbox, Inc., Medical Marijuana Inc. and Fusion Pharm to deliver technological advancements in the processing and use of cannabis in approved markets.
Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-
http://www.tmcnet.com/usubmit/2013/08/31/7379549.htm
Neutra Corp signs partnership agreement with Second Wave Ventures LLC
Neutra Corp partners with Second Wave Ventures, LLC to help revolutionize usage and processing of MMJ products in approved markets. (Photo : Reuters)
Neutra Corp (NTRR) announced that they have signed a letter of intent for a partnership with Second Wave Ventures, LLC. Cannabis Technologies, NTRR's MMJ (medical marijuana) subsidiary, the company is set on targeting potential partnerships with many California companies to help revolutionize medical marijuana usage by patients. The Second Waves Ventures partnership will align with the company's mission to develop and market new cannabis delivery systems. The process will eliminate the potential harmful side effects which are associated with drug.
Like Us on Facebook
"There's an untapped market out there for cannabinoid delivery systems infused with healthy nutraceuticals," Mr. Jim said. "Second Wave is working on groundbreaking products that deliver all of the benefits of medicinal cannabis while simultaneously counteracting the lack of energy and focus that many MMJ patients would prefer to eliminate."
NTRR's joint ventures with Vertigo Technologies, LLC and Field of View Technologies, LLC are part in the company's advancement plan for the usage and processing of cannabis in approved markets. The Second Wave partnership supports NTRR's plan to provide innovative services and products related to MMJ. Neutra Corp is set to follow the footsteps of Medical Marijuana Inc. (MJNA), Cannabis Science, Inc. (CBIS) and Terra Tech Corp. (TRTC).
Neutra Corp (NTRR) announced that they have signed a letter of intent for a partnership with Second Wave Ventures, LLC. Cannabis Technologies, NTRR's MMJ (medical marijuana) subsidiary, the company is set on targeting potential partnerships with many California companies to help revolutionize medical marijuana usage by patients. The Second Waves Ventures partnership will align with the company's mission to develop and market new cannabis delivery systems. The process will eliminate the potential harmful side effects which are associated with drug.
Like Us on Facebook
"There's an untapped market out there for cannabinoid delivery systems infused with healthy nutraceuticals," Mr. Jim said. "Second Wave is working on groundbreaking products that deliver all of the benefits of medicinal cannabis while simultaneously counteracting the lack of energy and focus that many MMJ patients would prefer to eliminate."
NTRR's joint ventures with Vertigo Technologies, LLC and Field of View Technologies, LLC are part in the company's advancement plan for the usage and processing of cannabis in approved markets. The Second Wave partnership supports NTRR's plan to provide innovative services and products related to MMJ. Neutra Corp is set to follow the footsteps of Medical Marijuana Inc. (MJNA), Cannabis Science, Inc. (CBIS) and Terra Tech Corp. (TRTC).